>>Signaling Pathways>> DNA Damage/DNA Repair>> Nucleoside Antimetabolite/Analogue>>2′-Deoxy-β-L-uridine

2′-Deoxy-β-L-uridine

Catalog No.GC67384

2'-Deoxy-β-L-uridine은 뉴클레사이드 유사체이며 바이러스 효소의 특정 기질이며 단순 헤르페스 1(HSV1) 티미딘 키나아제(TK)에 대해 입체 \u200b\u200b특이성을 나타내지 않습니다. 821d96072c2d58d8970e76f526b0f6b82′-데옥시-β-L-우리딘은 5'-트리포스페이트와 바이러스 DNA 중합효소의 상호작용을 통해 항바이러스 활성을 발휘합니다.821d96072c2d58d8970e76f526b0f6b8

Products are for research use only. Not for human use. We do not sell to patients.

2′-Deoxy-β-L-uridine Chemical Structure

Cas No.: 31501-19-6

Size 가격 재고 수량
250mg
US$2,250.00
재고 있음
500mg
US$3,001.00
재고 있음
1g
US$3,755.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

2'-Deoxy-β-L-uridine is a nucledside analogue and a specific substrate for the viral enzyme, shows no stereospecificity against herpes simplex 1 (HSV1) thymidine kinase (TK). 2′-Deoxy-β-L-uridine exerts antiviral activity via the interation of 5'-triphosphates with the viral DNA polymerase[1][2].

[1]. Spadari S, et al. L-thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth. J Med Chem. 1992 Oct 30;35(22):4214-20.
[2]. Lin TS, et al. Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human immunodeficiency virus (HIV) in vitro. J Med Chem. 1996 Apr 26;39(9):1757-9.

리뷰

Review for 2′-Deoxy-β-L-uridine

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 2′-Deoxy-β-L-uridine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.